Kallikrein 6 as a Serum Prognostic Marker in Patients with Aneurysmal Subarachnoid Hemorrhage

• Eduardo Martínez-Morillo,

  Affiliation Samuel Lunenfeld Research Institute, Joseph and Wolf Lebovic Health Centre, Mount Sinai Hospital, Toronto, Ontario, Canada

  ⨯
• Anastasia Diamandis,

  Affiliation Department of Clinical Biochemistry, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada

  ⨯
• Alexander D. Romaschin,

  Affiliation Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada

  ⨯
• Eleftherios P. Diamandis

  * E-mail: ediamandis@mtsinai.on.ca

  Affiliations Samuel Lunenfeld Research Institute, Joseph and Wolf Lebovic Health Centre, Mount Sinai Hospital, Toronto, Ontario, Canada, Department of Clinical Biochemistry, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada, Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada

  ⨯